Stark & Stark Announces Creation of Vioxx Trial Group

Stark & Stark has created the Vioxx Trial Group in response to Merck's voluntary withdrawal of Vioxx. New clincal data has shown an increased relative risk for heart attacks and strokes in people who have taken the drug.

(PRWEB) October 11, 2004 -- On Thursday September 30, Merck announced a voluntary worldwide withdrawal of its arthritis and acute pain medication Vioxx. According to a Merck press release, the decision was based on new, three-year data from a clinical trial, which showed an increased relative risk for heart attacks and strokes.

Stark & Stark, a preeminent full service law firm with offices in Princeton and Cherry Hill New Jersey and Philadelphia Pennsylvania has begun to review and accept injury cases from surviving family members and individuals who have been injured by taking Vioxx. With over 96 attorneys, 25 of who dedicate their practice to personal injury matters, Stark & Stark announces the establishment of its Vioxx Trial Group.

The Vioxx Trial Group is comprised of eight attorneys many of whom are certified trial attorneys by both State and National attorney certification boards. If you believe that you, or a member of your family, has been injured as a result of using Vioxx, contact Nadine Dunn or Megan Maminski at 1-800-535-3425 so your particular case can be reviewed by a member of the Vioxx Trial Group.

The dedication of Stark & Stark lawyers to exceptional legal service and technical expertise is evidenced by such honors as the inclusion of attorneys in Whos Who in American Law, the Best Lawyers in America and the Million Dollar Advocates Forum.

###